the results showed that there were no statistically significant differences in the measured bioavailability parameters ( area under plasma concentrations-time curve , maximum plasma concentration and time to reach maximum plasma concentration ) for pseudoephedrine from repeat action tablets and conventional d-pseudoephedrine sulfate tablets ;
C0033798
pseudoephedrine
C0304431
pseudoephedrine sulfate